Compare CL & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CL | COR |
|---|---|---|
| Founded | 1806 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.0B | 57.4B |
| IPO Year | N/A | N/A |
| Metric | CL | COR |
|---|---|---|
| Price | $79.77 | $341.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 13 |
| Target Price | $90.47 | ★ $354.85 |
| AVG Volume (30 Days) | ★ 6.0M | 1.5M |
| Earning Date | 01-30-2026 | 02-04-2026 |
| Dividend Yield | ★ 2.61% | 0.70% |
| EPS Growth | 2.56 | ★ 5.71 |
| EPS | 3.57 | ★ 7.96 |
| Revenue | $20,097,000,000.00 | ★ $321,332,819,000.00 |
| Revenue This Year | $3.88 | $7.20 |
| Revenue Next Year | $3.33 | $6.62 |
| P/E Ratio | ★ $22.33 | $42.85 |
| Revenue Growth | N/A | ★ 9.31 |
| 52 Week Low | $74.55 | $223.92 |
| 52 Week High | $100.18 | $377.54 |
| Indicator | CL | COR |
|---|---|---|
| Relative Strength Index (RSI) | 54.40 | 44.43 |
| Support Level | $77.77 | $336.41 |
| Resistance Level | $80.40 | $343.67 |
| Average True Range (ATR) | 1.30 | 5.45 |
| MACD | 0.20 | -0.69 |
| Stochastic Oscillator | 85.82 | 30.65 |
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one-fifth of sales), which sells a majority of its products through veterinarians and specialty pet retailers.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.